🐻 UNM ≈$1.7M Aggressive Call Sale — A Motivated Seller Caps Unum's Upside at the Top of the Street's Range
Last updated: 2026-06-09
✅ RESOLVED — Next-Day OI Update (2026-06-09): ✅ The $105 call OI rose 13 → 9,650 (+9,637). The aggressive below-bid call sale is on the books — confirmed.
📅 June 8, 2026 | 🔥 Unusual Activity Detected
🎯 The Quick Take
Someone hit the market with 9,500 Dec-18-2026 $105 calls on Unum Group — sold BELOW the bid — collecting ≈$1.7M in premium with spot at $87.31. This isn't a passive negotiated block with a willing counterparty sitting across the table. This was a seller who leaned on the market and accepted a worse-than-quoted price to get the trade done fast. Translation: a desk is telling you that UNM, trading at a 52-week high, will not clear $105 by December — a strike that sits at the very peak of analyst fair-value estimates — and they paid up in slippage to say it loudly.
📊 Company Overview
Unum Group (UNM) is the U.S. market leader in group disability insurance, supplemental health, and voluntary workplace benefits — the kind of insurance your employer buys so you still get paid when you're out sick for three months.
- Market Cap: ≈$13.96 billion
- Industry: Financials — Life & Health Insurance (NYSE: UNM)
- Core Segments: Unum US (group/voluntary disability, life, dental), Colonial Life (supplemental health & life), Unum International (UK/Poland), and a Closed Block of legacy long-term care (LTC) and individual disability policies
- Current Price: ≈$87.31 (at the time of the trade) — essentially at its 52-week high of $87.81
- 52-Week Range: $68.28 – $87.81
- Forward P/E: ≈9.7x — cheap on earnings, but growth is single-digit and mostly buyback-engineered
Real talk: Unum is a capital-return story, not a growth story. Q1 2026 results were record-setting — $2.14 adjusted EPS (beat by ≈4%), 21.7% core ROE — and the market has rewarded it by pushing the stock to an all-time-high zone. The question is what happens from here, which is exactly what this trade is betting on.
💰 The Option Flow Breakdown
📊 The Tape (June 8, 2026 @ 12:38:02)
| Time | Buy/Sell | Call/Put | Expiration | Premium | Strike | Volume | OI | Size | Spot | Option Price | Option Symbol |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12:38:02 | SELL | CALL | 2026-12-18 | ≈$1.7M | $105 | 23,000 | 13 | 9,500 | $87.31 | $1.75 | UNM20261218C105 |
Flow-type note: AGGRESSIVE — sold below the bid (a motivated seller). This is NOT a passive negotiated cross.
This distinction matters and is worth understanding clearly:
A negotiated block cross (like many large trades you'll see) involves a broker matching a buyer AND seller off the open book — both sides agreed to the price in advance, there's no urgency, and you can't read directional conviction from it. This trade is different. Selling BELOW the bid means the seller accepted a worse price than what the market was already offering — they sacrificed edge to get filled immediately. That's real urgency. A seller willing to take slippage has conviction and a reason to move fast. It makes this print more signal-rich than a cross, even though both involve premium collection.
⏳ Open/Close: Fresh Open — Predict OI +9,500 Contracts by Tomorrow Morning
The prior OI on UNM20261218C105 at the time of the trade was just 13 contracts — essentially no prior activity on this strike. Volume of 9,500 contracts against OI of only 13 means virtually the entire trade was a fresh open (Vol/OI ≈ 731×). This is a new position, not a close.
Order type: STO (Sell-to-Open) — the seller COLLECTED ≈$1.7M in credit. This is not $1.7M paid. It is $1.7M received. The trade's risk profile is the opposite of a directional buyer's.
Expected next-day OI check: Look for UNM20261218C105 OI to rise from 13 to approximately ≈9,500–9,513 on the June 9 pre-market OPRA snapshot (≈06:30 ET). If OI rises by ≈9,500, the fresh STO open is confirmed. If OI is unchanged or down, investigate for cancellations. The massive Vol/OI ratio here makes the open classification highly reliable, but always verify.
🤓 What This Actually Means — Plain English
Let's break this trade down the way you'd explain it to a friend over coffee.
Step 1: What does "selling a call" actually mean?
When you sell a call option (STO = Sell to Open), you are not betting on the stock going up. You are doing the opposite — you're collecting cash today in exchange for a promise: if UNM stock rises above $105 by December 18, 2026, you owe the buyer the difference. The $1.75/contract they paid you is yours to keep no matter what.
The math:
- 9,500 contracts × 100 shares × $1.75 = $1,662,500 in premium collected (≈$1.7M)
- Maximum profit: The full ≈$1.7M — if UNM stays below $105 through December 18, the calls expire worthless and the seller keeps everything
- Breakeven at expiration: $105 + $1.75 = $106.75 — UNM must trade above $106.75 at expiry for the seller to lose money
- Strike is ≈20.3% above today's spot — UNM would need to rally $17.69 from $87.31 to reach the strike
Step 2: Why is "sold BELOW the bid" the key detail?
When you sell options, the bid price is what the market is willing to pay you. Hitting BELOW the bid means the seller took a price even worse than that — they accepted slippage to get filled immediately. Compare that to a negotiated block cross: in a cross, a broker lines up a buyer and a seller who agree on a price beforehand, with no urgency on either side. There's a willing counterparty. No one is in a rush.
Here, there's no lined-up buyer. The seller walked to the market, accepted a worse price, and pushed through 9,500 contracts. That urgency makes this print carry more directional information — a motivated, opinionated seller, not a routine institutional adjustment.
Step 3: What is the seller actually saying?
The position is neutral-to-bearish on UNM's upside. Specifically:
- UNM is at ≈$87, and the $105 strike sits at or above every major analyst's 12-month price target (Street average ≈$97–98, Street high $108 from Raymond James). KBW's top target is $105; Wells Fargo just raised to $104. The seller is monetizing the very low odds that UNM eclipses the bulliest analysts' fair value by December.
- The seller believes the record Q1 results, dividend hike, and $1B buyback — all the good news — are already priced in at the 52-week high. There's no explosive catalyst left that sends a slow-moving disability insurer up 20% in six months.
- The one big remaining 2026 catalyst, the annual LTC reserve review, is a neutral-to-negative risk (Q1's LTC update was a −$643.1M hit). Not the kind of event that launches a stock to $105.
This is a premium-collection, capped-upside trade by a desk with a clear view: UNM is range-bound below $105 through December. The ≈$1.7M is income for being right about that range.
📈 Technical Setup / Chart Check-Up
YTD Performance

UNM has had a steady 2026 — tracking broadly flat-to-slightly higher through the year after recovering from a dip earlier in the spring. The stock is now sitting essentially at its 52-week high of $87.81, supported by the record Q1 print and enthusiasm around the $1B buyback. The move to this level reflects the good news being priced in. Now comes the harder part: convincing the market to push beyond the fair-value band when the remaining catalysts are mixed at best.
🔵🟠 Gamma-Based Support & Resistance

Current Price: ≈$87.39 (per GEX snapshot)
The gamma structure for UNM is concentrated and tells a clear near-term story:
🟠 Call Gamma Resistance (Orange Bars — Overhead Sellers):
- $90.00 — Moderate resistance, 0.808B total GEX, net GEX +0.805B call-dominant. This is the first real ceiling above spot — just ≈$2.61 away. Market makers will lean against rallies toward $90.
- $95.00 — Lighter resistance, 0.122B total GEX, net GEX +0.122B. A secondary wall if $90 gives way, but thin — less defense here.
🔵 Put Gamma Support (Blue Bars — Downside Floors):
- $85.00 — Strong support, 2.669B total GEX, net GEX +2.584B call-dominant at $85. This is the dominant gamma anchor on the board — the largest single level. Market makers will buy UNM aggressively if price tests $85.
- $82.50 — Moderate support, 0.401B total GEX — a secondary floor.
- $80.00 — Lighter support, 0.304B total GEX with a net put-dominant GEX of −0.121B — some downside defense exists at $80 but it's not thick.
What this means for you: UNM is sandwiched between massive $85 support (2.669B GEX — the single biggest level on the chain) and $90 call-gamma resistance (0.808B GEX). The ≈$2.31 gap from spot to $85 is your near-term cushion on the downside. The ≈$2.61 gap to $90 is the near-term lid on the upside. A $105 breakout by December is far outside this near-term gamma structure — it requires sustained, multi-month price appreciation well beyond any current gamma wall. The call seller's thesis is that the gamma structure here is consistent with range-bound behavior: strong defense at $85, resistance at $90, and nothing in the chain that currently anticipates a run to $105.
📐 Implied Move Analysis

The options market's implied volatility embeds concrete range expectations by expiry:
| Timeframe | Expiry | Implied Move | Upper Range | Lower Range |
|---|---|---|---|---|
| Weekly | 2026-06-18 | ±4.2% / ±$3.63 | $91.04 | $83.78 |
| Monthly OPEX | 2026-07-17 | ±7.4% / ±$6.48 | $93.89 | $80.93 |
| Quarterly Triple Witch | 2026-09-18 | ±14.3% / ±$12.51 | $99.92 | $74.90 |
The key number for this trade: Is $105 within the implied move to December?
The Dec-18-2026 expiry is ≈193 days out. The September triple-witch implied move already caps the upper range at $99.92 — that's ≈102 days out and the ceiling is still nearly $5 below the $105 strike. By December, extrapolating further time value, the implied upper range would need to expand another ≈$5+ just to reach $105. The options market is not pricing in a $105 UNM by year-end.
The seller of the Dec $105 calls is using that gap as a cushion. Even the September implied move barely reaches $100. For the calls to go in-the-money, UNM would need to substantially exceed the implied-move upper bounds — not just once, but sustain it through December 18.
🎪 Catalysts
✅ Already Happened — In the Books
- Q1 2026 Record Earnings (late April 2026): Adjusted operating EPS of $2.14, beating $2.05 consensus (+4.4%), revenue ≈$3.36B vs ≈$2.98B expected. Core ROE ≈21.7%. The stock initially popped ≈5% after-hours. This is already in the price.
- $1 Billion Share Buyback (January 1, 2026): New $1B authorization — ≈8.2% of shares outstanding. Q1 2026 alone saw ≈$400M deployed — the single biggest near-term EPS driver for this slow-growing insurer. Already known and priced.
- ≈10% Dividend Hike (announced with Q1): Dividend stepping up to $0.505/quarter ($2.02 annualized), payable starting Q3 2026. Already priced.
- $3.4 Billion LTC Reinsurance Transaction — Closed 2025: Unum closed a major individual-LTC coinsurance deal with Fortitude Re, shrinking legacy closed-block exposure. Significant risk reduction, but now a 2025 news item.
- Q1 2026 LTC Reserve Hit: −$643.1M (assumption update): Disclosed in the Q1 8-K — the annual LTC actuarial review produced a large negative surprise. This is the tail risk that keeps surfacing. A reminder, not a catalyst.
- Analyst Upgrades Post-Q1: KBW raised to $105, Wells Fargo raised to $104, Truist raised to $96. Notably, Morgan Stanley pegs fair value at $87 — effectively current spot, which is a "we see no upside from here" view from a major bank. Upgrades are in; the stock already reflects them.
🔭 Upcoming — What Could Move UNM Between Now and December 18
- Q2 2026 Earnings: ≈July 28, 2026 — Per MarketBeat earnings calendar. Watch: 2026 guidance of 4–7% top-line growth and 8–12% EPS growth; benefit ratios; buyback pace; any LTC commentary. A clean beat could push UNM toward $90–95 (within the gamma band and the Street's mid-target range). An LTC surprise would pressure the stock. This is the biggest near-term swing event.
- Q3 2026 Earnings: ≈Late October 2026 — The quarter the higher $0.505 dividend first hits. Per Simply Wall St, a modest sentiment positive for income investors but not a re-rating catalyst.
- Annual LTC Reserve Review (back-half 2026): Per the SEC 8-K history, Unum's biggest actuarial true-up is historically a second-half event. The Q1 −$643.1M update already happened in April, but additional LTC reserve actions remain the most meaningful discrete catalyst risk through December. This is a neutral-to-negative skew for the stock — a new adverse update would cap any rally; a positive (additional risk transfer) would be incrementally good but not transformational.
- Possible Additional LTC Risk Transfer: Management explicitly stated it continues evaluating further risk-transfer opportunities following the Fortitude Re deal. A Fortitude-style transaction would be a sentiment positive. Still: it de-risks the tail, it doesn't create a growth story.
- Interest Rate Sensitivity: As a long-duration liability holder, Unum benefits from higher-for-longer rates. Any accelerating Fed rate-cut cycle into 2026 is a slow headwind on investment income and LTC discount-rate assumptions — not binary, but a steady valuation drag.
💡 Trading Ideas
🛡️ Conservative — "Income on a Range-Bound Insurer, Mirroring the Smart Money"
For premium collectors and covered-call writers with $10K–$50K, income focus
The desk's trade is essentially an overwrite — selling calls far above spot to collect premium on a slow mover. You can replicate the concept at a smaller scale and with more manageable risk:
- 🎯 If you already own UNM stock: Consider selling near-dated $90 or $92.50 calls against your position (covered call). With the $90 gamma wall already showing resistance at 0.808B GEX, this strike captures the near-term ceiling. You collect premium every month, and if called away you exit near fair value.
- 📅 Near-term covered-call cycle: July 17 OPEX ($93.89 upper implied range) is your cap reference. Selling the $92 or $93 call for July expiration captures the maximum implied move with defined assignment risk.
- 💰 Why this works: UNM is a low-beta insurer at a 52-week high. Monthly theta decay on near-OTM calls tends to be consistent on stocks with this profile. The gamma data confirms strong $85 support below — your downside floor if the stock dips.
Cost / risk: Capped upside if UNM rips through the call strike. The covered call removes the lottery-ticket upside. Max loss is stock decline (cushioned by premium collected).
⚖️ Balanced — "Wait for Q2 Earnings and Play the Range"
For swing traders, $10K–$40K, 6-8 week horizon
The Q2 earnings print at ≈July 28 is the next binary event. The implied move by July 17 OPEX is ±7.4% (upper ≈$93.89, lower ≈$80.93). A clean Q2 beat-and-raise with stable LTC commentary could push UNM toward $90–94 — squarely inside the gamma resistance zone. That's not a $105 scenario; it's an $8–10 move.
Structure (illustrative):
- 📈 Buy UNM $87.50 Call, 2026-08-21 expiration (first OPEX after Q2 — August monthly, implied upper ≈$97.34)
- 📉 Sell UNM $95.00 Call, 2026-08-21 expiration (just below the Street's average target, resistance zone)
- 💰 Net debit: verify live, estimate ≈$2.50–$3.50 per spread
- 🎯 Max profit: ≈$7.50 if UNM is above $95 at August OPEX
- ⚠️ Max loss: the net debit paid
Why this works: You're playing the range — $87.50 to $95 by August 21. The upper target sits just below the ≈$97–98 consensus target, within the August implied-move upper bound of $97.34. Defined risk, captures a Q2 beat without needing a $105 melt-up.
🚀 Aggressive — "Fade the Rally With Near-Dated Puts if LTC Surprises"
For experienced options traders, $5K–$20K, event-driven
The highest-conviction bearish setup is around the annual LTC reserve review, which historically lands in the second half. If you believe the LTC tail is underpriced (the Q1 hit was −$643.1M, and there's ≈$2.2B of "Fairwind" protection still in place), you can position for a Q3 or Q4 miss.
- 🐻 Buy a September 18 $82.50 Put (≈$7.50–$9 below spot, within the September implied lower range of $74.90)
- 🎯 Target: $80–$82.50 on an adverse LTC update or Q2 guidance cut
- ⚠️ Max loss: the premium paid (define your max spend)
Why this works: September lower implied bound is $74.90 — the market is pricing in the possibility of a significant down move. An LTC reserve shock (like the −$643.1M in Q1) could easily push toward $80 and below. The $85 gamma support provides real resistance, but gamma walls don't hold against fundamental surprises — they slow the move, not stop it.
Warning: This is an event-driven bet. If the LTC review is benign and Q2 beats cleanly, you lose the put premium.
🎲 Price Targets & Scenarios Through December 18, 2026
Using gamma levels, implied move data, and the catalyst calendar:
📈 Bull Case (20% probability by December 18, 2026)
Target: $95–$100 (still below the $105 strike)
How UNM gets there: two consecutive clean beats (Q2 + Q3), aggressive buyback execution consuming the full $1B authorization faster than expected, and no LTC negative surprises. Raymond James' $108 target and the September implied upper bound of $99.92 define the realistic ceiling. At $95–$100, the Dec $105 calls still expire worthless — the seller wins even in the bull case.
For the call seller: Even the bull case likely leaves the $105 strike out-of-the-money. That's the elegance of the trade — the strike is set above almost every analyst's upside target.
🎯 Base Case (55% probability)
Target: $85–$93 range through December 2026
UNM tracks sideways-to-modestly higher, delivering on guidance but with no multiple-expansion catalyst. Buybacks steadily reduce the share count. The $90 gamma resistance keeps a lid on short-term rallies. The stock oscillates in a $85–93 band — right in the gamma pinch zone between the major $85 support and $90 resistance — with occasional pops on earnings beats that fade.
For the call seller: Both $105 calls expire worthless. Full ≈$1.7M credit kept. This is the highest-probability outcome.
📉 Bear Case (25% probability)
Target: $75–$82 (LTC surprise or macro shock)
A material adverse LTC reserve update in back-half 2026, a benefit-ratio normalization that compresses margins, or a sharp rate-cut cycle that pressures investment income. The $85 gamma floor (2.669B GEX) would slow the decline, but fundamental surprises override gamma. The September implied lower bound is $74.90 — the market is embedding this scenario at a non-trivial probability.
For the call seller: Still wins — the $105 calls expire worthless, and the ≈$1.7M premium is fully collected. The short-call position has no downside to the stock falling. However, if the seller also owns UNM stock (covered call scenario), stock losses are not offset by the call premium beyond the $1.75 received.
⚠️ Risks & Honest Limits
What the tape CAN tell us:
- 9,500 contracts sold, 23,000 total volume, prior OI of 13 → overwhelmingly a fresh STO open
- The print occurred below the bid — a motivated seller with urgency, not a passive block
- Order type STO with MEDIUM confidence (no prior archive position found within 180 days; Vol/OI ratio of ≈1,769× strongly supports a new open)
What the tape CANNOT tell us:
- Broker or counterparty identity: We do not know who sold these calls. It could be a hedge fund overwriting an existing long stock position (a covered call at scale), a vol-selling desk fading post-earnings IV, or a directional short-vol bet. The economics and urgency are the same either way, but the motive matters for interpreting risk.
- Whether this is covered or naked: If the seller owns 950,000 shares of UNM (9,500 contracts × 100), this is a covered call — defined risk, income-generating. If the seller has no offsetting stock position, this is a naked short call — theoretically unlimited loss risk above $106.75. Naked short calls require substantial margin. Never sell naked calls without understanding the margin requirements and unlimited upside risk.
- The full position context: This could be one leg of a larger structure (cap, collar, overwrite). We only see the option tape, not the equity or other-leg activity.
Key structural risk:
- A genuine surprise catalyst that pushes UNM above $106.75 by December 18 generates losses for the seller on every dollar above that breakeven. While unlikely given the analysis above, tail risks include: a transformational LTC reinsurance deal that spurs a major analyst re-rating, a sector rotation into low-beta financials driving multiple expansion, or macro developments that significantly raise the group-disability market's growth outlook.
- Morgan Stanley's $87 target (Equal-Weight) is a reminder that one major bank sees no upside from here at all — the stock being at fair value on their model is also a signal that downside catalysts are not fully priced out.
🎯 The Bottom Line
Here's the deal: A desk sold 9,500 UNM December $105 calls below the bid — aggressively, urgently, and at a strike that sits above almost every analyst's 12-month price target. They collected ≈$1.7M to say: this slow-moving disability insurer, at a 52-week high with all its good news already priced in, will not rally 20% by December. The gamma structure agrees ($90 resistance is the first real lid), the implied-move data agrees (September upper range barely reaches $100), and the catalyst calendar agrees (remaining 2026 events skew neutral-to-negative via LTC reserve risk, not bullish growth surprises).
What this trade tells you:
- 🐻 A motivated, urgent seller has strong conviction that UNM is capped below $105 through year-end
- 💰 The $105 strike was chosen deliberately — it's at the top of the Street's fair-value band (KBW $105, Wells Fargo $104), making the calls cheap to sell with low probability of going in-the-money
- ⚡ Selling BELOW the bid is the key signal that separates this from routine flow — urgency and conviction, not a passive adjustment
- 🔑 STO = the seller COLLECTED $1.7M. This is income for being right about a range, not a crash bet
If you own UNM:
- ✅ The $85 gamma floor (2.669B GEX — the biggest level on the board) is your near-term support. A test-and-hold of $85 is where market makers will defend aggressively.
- 🎯 Watch $90 as the near-term ceiling (0.808B GEX call-dominant). A clean Q2 beat on July 28 could push toward $90–95 before fading.
- 🤔 Consider whether you want to mirror the smart money with a covered call — selling the $90 or $92 for July OPEX collects income while the stock chops.
If you're watching from the sidelines:
- 📅 July 28, 2026 — Q2 earnings is the next catalyst that could actually move the stock. The range: ±7.4% implied move ($80.93–$93.89 by July 17 OPEX).
- 📅 Back-half 2026 — Watch for any LTC reserve update announcement. A material negative update is the bear-case trigger.
- 📅 June 9, 2026 pre-market (≈06:30 ET) — Check UNM20261218C105 OI; STO confirmed if OI rises from 13 to ≈9,500+.
Mark your calendar:
- 📅 June 9, 2026 pre-market — OI confirmation check (STO open expected +9,500)
- 📅 July 28, 2026 — Q2 FY26 earnings
- 📅 Late October 2026 — Q3 FY26 earnings (first quarter with higher $0.505 dividend)
- 📅 Back-half 2026 — Annual LTC reserve review (the tail risk event)
- 📅 December 18, 2026 — Option expiration date
Final verdict: This is a sophisticated premium-collection trade by a seller with clear market views and the conviction to hit below the bid to execute. The thesis is well-supported: slow insurer, 52-week high, record results already priced, $105 strike above every reasonable near-term target, remaining catalysts skewing neutral-to-negative. The ≈$1.7M keeps rolling in as long as UNM stays below $105 — and the market's own implied-move data says that's the most likely outcome. Don't mistake STO income for a stock crash bet. And don't sell naked calls without doing your margin math first.
Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. Short call positions (STO) carry theoretically unlimited loss risk above the breakeven price if not covered by an underlying stock position. The ≈$1.7M premium collected in this trade is fully at risk if UNM trades above $106.75 by December 18, 2026. The order-type classification (STO) is MEDIUM confidence — based on massive Vol/OI evidence (9,500 vs 13 prior OI) — but open/close is definitively confirmed by the June 9 OPRA OI snapshot. This analysis is for educational purposes only and does not constitute financial advice. Always do your own research and consult a licensed financial advisor before trading options. Past unusual options activity does not guarantee profitable trading outcomes.
Last updated: 2026-06-08
About Unum Group: Unum Group is the U.S. market leader in group disability insurance, supplemental health, and voluntary workplace benefits. Market cap ≈$13.96B. Sector: Financials — Life & Health Insurance. The company operates through Unum US, Colonial Life, Unum International, and a legacy Closed Block of long-term care and individual disability policies. Q1 2026 adjusted operating EPS of $2.14 was a record, with core ROE of ≈21.7% and ≈$400M returned to shareholders in the quarter alone.